Joel M. Kaufman

3.8k total citations
61 papers, 2.7k citations indexed

About

Joel M. Kaufman is a scholar working on Urology, Endocrinology, Diabetes and Metabolism and Psychiatry and Mental health. According to data from OpenAlex, Joel M. Kaufman has authored 61 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Urology, 23 papers in Endocrinology, Diabetes and Metabolism and 23 papers in Psychiatry and Mental health. Recurrent topics in Joel M. Kaufman's work include Sexual function and dysfunction studies (23 papers), Hormonal and reproductive studies (23 papers) and Urinary Bladder and Prostate Research (18 papers). Joel M. Kaufman is often cited by papers focused on Sexual function and dysfunction studies (23 papers), Hormonal and reproductive studies (23 papers) and Urinary Bladder and Prostate Research (18 papers). Joel M. Kaufman collaborates with scholars based in United States, Germany and Canada. Joel M. Kaufman's co-authors include Ridwan Shabsigh, Harin Padma-Nathan, Christopher P. Steidle, John P. Hayslett, R. James Graydon, Norman J. Siegel, Stephen C. Jacobs, J. Edwin Seegmiller, Martin L. Greene and Irwin Goldstein and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation Research.

In The Last Decade

Joel M. Kaufman

60 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joel M. Kaufman United States 28 1.2k 1.2k 738 525 394 61 2.7k
Leroy M. Nyberg United States 39 690 0.6× 924 0.8× 3.8k 5.2× 244 0.5× 50 0.1× 87 5.8k
Kalyana Nandipati United States 23 274 0.2× 470 0.4× 325 0.4× 168 0.3× 57 0.1× 56 1.7k
Kathleen M. Hoeger United States 28 815 0.7× 86 0.1× 109 0.1× 376 0.7× 144 0.4× 65 4.4k
Laure Morin‐Papunen Finland 43 1.1k 0.9× 85 0.1× 106 0.1× 494 0.9× 79 0.2× 121 5.0k
Nikolaos Alexopoulos Greece 26 283 0.2× 196 0.2× 63 0.1× 311 0.6× 44 0.1× 66 2.6k
Martin Buysschaert Belgium 29 1.4k 1.1× 124 0.1× 35 0.0× 583 1.1× 29 0.1× 155 3.2k
Fikret Erdemi̇r Türkiye 21 173 0.1× 134 0.1× 326 0.4× 223 0.4× 23 0.1× 102 1.5k
L. Elaine Waetjen United States 23 711 0.6× 120 0.1× 307 0.4× 130 0.2× 41 0.1× 49 2.3k
Melanie A. Lane United States 17 1.1k 0.9× 98 0.1× 42 0.1× 481 0.9× 28 0.1× 18 2.5k
Britta Hylander Sweden 28 211 0.2× 92 0.1× 56 0.1× 134 0.3× 59 0.1× 94 2.2k

Countries citing papers authored by Joel M. Kaufman

Since Specialization
Citations

This map shows the geographic impact of Joel M. Kaufman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel M. Kaufman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel M. Kaufman more than expected).

Fields of papers citing papers by Joel M. Kaufman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel M. Kaufman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel M. Kaufman. The network helps show where Joel M. Kaufman may publish in the future.

Co-authorship network of co-authors of Joel M. Kaufman

This figure shows the co-authorship network connecting the top 25 collaborators of Joel M. Kaufman. A scholar is included among the top collaborators of Joel M. Kaufman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel M. Kaufman. Joel M. Kaufman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaufman, Joel M., Michael G. Miller, Sherahe Fitzpatrick, Cecilia McWhirter, & John J. Brennan. (2012). One‐Year Efficacy and Safety Study of a 1.62% Testosterone Gel in Hypogonadal Men: Results of a 182‐Day Open‐Label Extension of a 6‐Month Double‐Blind Study. The Journal of Sexual Medicine. 9(4). 1149–1161. 16 indexed citations
2.
McMahon, Chris G., Stanley E. Althof, Joel M. Kaufman, et al.. (2010). Efficacy and Safety of Dapoxetine for the Treatment of Premature Ejaculation: Integrated Analysis of Results from Five Phase 3 Trials. The Journal of Sexual Medicine. 8(2). 524–539. 124 indexed citations
3.
4.
Shabsigh, Ridwan, et al.. (2010). Lack of awareness of erectile dysfunction in many men with risk factors for erectile dysfunction. BMC Urology. 10(1). 18–18. 31 indexed citations
5.
Kaufman, Joel M., et al.. (2008). Cylinder Aneurysm of Parylene-Coated American Medical System (AMS) 700CX Penile Prosthesis. The Journal of Sexual Medicine. 5(11). 2713–2715. 8 indexed citations
6.
Kaufman, Joel M. & Johannes W. Dietrich. (2006). SAFETY AND EFFICACY OF AVANAFIL, A NEW PDE5 INHIBITOR FOR TREATING ERECTILE DYSFUNCTION. European Urology Supplements. 5(2). 138–138. 11 indexed citations
7.
Kaufman, Joel M. & John W. Dietrich. (2006). 923: Safety and Efficacy of Avanafil, A New Phosphodiesterase Type-5 (PDE-5) Inhibitor for Treating Erectile Dysfunction. The Journal of Urology. 175(4S). 299–299. 8 indexed citations
8.
Jockenhövel, F., et al.. (2005). The good, the bad, and the unknown of late onset hypogonadism: the urological perspective. The Journal of Men s Health and Gender. 2(3). 292–301. 4 indexed citations
9.
Kaufman, Joel M.. (2005). A rational approach to androgen therapy for hypogonadal men with prostate cancer. International Journal of Impotence Research. 18(1). 26–31. 7 indexed citations
10.
Shabsigh, Ridwan, Joel M. Kaufman, Christopher P. Steidle, & Harin Padma-Nathan. (2004). RANDOMIZED STUDY OF TESTOSTERONE GEL AS ADJUNCTIVE THERAPY TO SILDENAFIL IN HYPOGONADAL MEN WITH ERECTILE DYSFUNCTION WHO DO NOT RESPOND TO SILDENAFIL ALONE. The Journal of Urology. 172(2). 658–663. 303 indexed citations
11.
12.
Brown, Jeanette S., Jean F. Wyman, Kathryn L. Burgio, et al.. (2003). Measurement characteristics of a voiding diary for use by men and women with overactive bladder. Urology. 61(4). 802–809. 123 indexed citations
13.
14.
Shabsigh, Ridwan, Harin Padma-Nathan, Marc Gittleman, et al.. (2000). Intracavernous alprostadil alfadex (EDEX/VIRIDAL) is effective and safe in patients with erectile dysfunction after failing sildenafil (Viagra). Urology. 55(4). 477–480. 60 indexed citations
15.
Kaufman, Joel M., et al.. (1993). Evaluation of erectile dysfunction by dynamic infusion cavernosometry and cavernosography (DICC) Multi-institutional study. Urology. 41(5). 445–451. 27 indexed citations
16.
Kaufman, Joel M., et al.. (1980). Potentiation of warfarin by trimethoprim-sulfamethoxazole. Urology. 16(6). 601–603. 17 indexed citations
17.
Kaufman, Joel M., Bushra A. Fam, Stephen C. Jacobs, et al.. (1977). Bladder Cancer and Squamous Metaplasia in Spinal Cord Injury Patients. The Journal of Urology. 118(6). 967–971. 181 indexed citations
18.
Kaufman, Joel M., Robert J. Hardy, & John P. Hayslett. (1975). Age-dependent characteristics of compensatory renal growth. Kidney International. 8(1). 21–26. 80 indexed citations
19.
Kaufman, Joel M., et al.. (1974). Compensatory adaptation of structure and function following progressive renal ablation. Kidney International. 6(1). 10–17. 131 indexed citations
20.
Kaufman, Joel M. & William M. O’Brien. (1967). Hyperuricemia in Mongolism. New England Journal of Medicine. 276(17). 953–956. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leroy M. Nyberg Breakdown of academic impact, for papers by Kalyana Nandipati Breakdown of academic impact, for papers by Kathleen M. Hoeger Breakdown of academic impact, for papers by Laure Morin‐Papunen Breakdown of academic impact, for papers by Nikolaos Alexopoulos Breakdown of academic impact, for papers by Martin Buysschaert Breakdown of academic impact, for papers by Fikret Erdemi̇r Breakdown of academic impact, for papers by L. Elaine Waetjen Breakdown of academic impact, for papers by Melanie A. Lane Breakdown of academic impact, for papers by Britta Hylander
Rankless by CCL
2026